In vivo imaging of functional neuroanatomy: positron emission tomography
Baron, J.C.
Bulletin de l'Association des Anatomistes 75(229): 85-88
1991
ISSN/ISBN: 0376-6160 PMID: 1777724 Document Number: 374908
Document emailed within 1 workday
Related Documents
Loken, M.K.; Hawkins, R.A.; Gupta, N.C.; Frick, M.P. 1989: Positron emission tomography (PET): a unique approach for the imaging of in vivo metabolism Nebraska Medical Journal 74(11): 333-339Kjaer, A. 2005: Molecular imaging with positron emission tomography and single photon emission computer tomography. Status and perspectives Ugeskrift for Laeger 167(48): 4549-4552
Rodriguez, M. 1998: Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma Acta Radiologica. Supplementum 417: 1-36
Zhang, H-juan.; Zhan, F-hua.; Li, Y-jun.; Sun, H-ran.; Bai, R-ju.; Gao, S. 2011: Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report Chinese Medical Journal 124(14): 2237-2240
Itoh, M.; Kikuchi, R.; Uruma, T.; Tsuji, T.; Kuroda, Y.; Watanabe, H.; Nakamura, H.; Aoshiba, K. 2014: All-in-one imaging of polymyositis, lung cancer and its metastatic lesions by fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography Acta Reumatologica Portuguesa 39(3): 283-284
Nasseri, Y.; Ourian, A.J.; Waxman, A.; D'Angolo, A.; Thomson, L.E.; Margulies, D.R. 2012: Fluorodeoxyglucose positron emission tomography-computed tomography: a novel approach for the diagnosis of cholecystitis for equivocal diagnoses after ultrasound imaging American Surgeon 78(10): 1109-1113
Ouichka, R.; Bouderraoui, F.; Raynal, M.; Melchior, J.; Morel, O.; Blum, A.; Chary-Valckenaere, I.; Ngueyon Sime, W.; Roch, V.ér.; Maksymowych, W.; Lambert, R.G.; Olivier, P.; Loeuille, D. 2019: Performance of 18F-sodium fluoride positron emission tomography with computed tomography to assess inflammatory and structural sacroiliitis on magnetic resonance imaging in axial spondyloarthritis Clinical and Experimental Rheumatology 37(1): 19-25
Imahori, Y.; Sasajima, H.; Mineura, K.; Imahori, Y. 2005: Molecular imaging for brain tumor using positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 250-257
Wiyaporn, K.; Tocharoenchai, C.; Pusuwan, P.; Ekjeen, T.; Leaungwutiwong, S.; Thanyarak, S. 2010: Factors affecting standardized uptake value (SUV) of positron emission tomography (PET) imaging with l8F-FDG Journal of the Medical Association of Thailand 93(1): 108-114
Hoekstra, C.J.; Hoekstra, O.S.; Teengs, J.P.; Postmus, P.E.; Smit, E.F. 1999: Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography Clinical Nuclear Medicine 24(7): 529-530
Shinotoh, H.; Aotsuka, A.; Inoue, O.; Suzuki, K.; Fukuda, H.; Iyo, M.; Yamazaki, T.; Tateno, Y.; Hirayama, K.; Nohara, N. 1991: Imaging of dopamine D1 and D2 receptors by a high resolution positron emission tomography Advances in Experimental Medicine and Biology 287: 249-253
Hargreaves, R. 2002: Imaging substance P receptors (NK1) in the living human brain using positron emission tomography Journal of Clinical Psychiatry 63 Suppl. 11: 18-24
Bolwig, T.G.; Haunsø, S.; Hove, J.D.; Hesse, B.; Højgaard, L.; Jensen, M.; Paulson, O.B.; Svendsen, J.H.; Sørensen, S.S. 1994: Positron emission tomography. a new measurement method for imaging of regional and biochemical parameters Ugeskrift for Laeger 156(43): 6341-6347
Eustache, F.; Desgranges, B.; De-La-Sayette, V.; Lalevee, C.; Giffard, B.; Piolino, P.; Viader, F.; Baron, J.C. 2001: Contribution of positron emission tomography to functional neuroimaging in Alzheimer's disease Revue Neurologique (Paris) 157(4): 377-383
Camaggi, V.; Piscaglia, F.; Bolondi, L. 2007: Recent advances in the imaging of hepatocellular carcinoma. From ultrasound to positron emission tomography scan Saudi Medical Journal 28(7): 1007-1014
Tsai, M-Hsui.; Huang, W-Sheng.; Tsai, J.J.; Chen, Y-Kung.; Changlai, S-Pin.; Kao, C-Hung. 2003: Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings Anticancer Research 23(4): 3513-3516
Koshi, Y.; Kitamura, S.; Sakayori, O.; Komaba, Y.; Terashi, A. 1995: Cerebello-cerebral functional relationship in spinocerebellar degeneration using positron emission tomography Rinsho Shinkeigaku 35(7): 751-757
Melder, R.J.; Brownell, A.L.; Shoup, T.M.; Brownell, G.L.; Jain, R.K. 1993: Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors Cancer Research 53(24): 5867-5871
Mautner, V.F.; Brenner, W.; Fünsterer, C.; Hagel, C.; Gawad, K.; Friedrich, R.E. 2007: Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1 Anticancer Research 27(4a): 1819-1822
Seitz, U.; Wagner, M.; Vogg, A.T.; Glatting, G.; Neumaier, B.; Greten, F.R.; Schmid, R.M.; Reske, S.N. 2001: In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model Cancer Research 61(10): 3853-3857